Department of Anesthesiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Department of Clinical Neurophysiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
World Neurosurg. 2021 Mar;147:e516-e523. doi: 10.1016/j.wneu.2020.12.099. Epub 2020 Dec 29.
Intradural extramedullary spinal cord tumors (ID-EMSCT) make up 40% of all spinal neoplasms. Resection of these tumors is mostly conducted using intraoperative neuromonitoring (IONM). However, the literature shows heterogenous data on its added value for ID-EMSCT. The aim of this study is to define sensitivity and specificity of IONM in ID-EMSCT resection and to study possible correlations between preoperative, intraoperative, and postoperative variables and neurologic outcomes after ID-EMSCT resection.
Data of patients undergoing ID-EMSCT surgeries with IONM from January 2012 until July 2019 were examined. Using neurologic status 6 weeks and 1 year postoperatively, sensitivity and specificity for IONM were calculated. IONM test results and neurologic outcomes were paired to preoperative, intraoperative, and postoperative parameters.
Data of 78 patients were analyzed. 6 weeks postoperatively, 14.10% of patients had worse neurologic status, decreasing to 9.84% 1 year postoperatively. Multimodal IONM showed a sensitivity of 0.73 (95% confidence interval [CI], 0.39-0.94) and a specificity of 0.78 (95% CI, 0.66-0.87) after 6 weeks, and a sensitivity of 1.00 (95% CI, 0.54-1.00) and a specificity of 0.71 (95% CI, 0.57-0.82) after 1 year.
IONM yielded high to perfect sensitivity and high specificity. However, IONM signals did not always determine the extent of resection, and false-positive results did not always result in incomplete tumor resections, because of surgeons overruling IONM. Therefore, IONM cannot fully replace clinical judgment and other perioperative information.
硬脊膜外髓内脊髓肿瘤(ID-EMSCT)占所有脊髓肿瘤的 40%。这些肿瘤的切除主要采用术中神经监测(IONM)。然而,文献中关于其对 ID-EMSCT 的附加值的数据存在差异。本研究旨在确定 IONM 在 ID-EMSCT 切除中的灵敏度和特异性,并研究 ID-EMSCT 切除前后手术、术中及术后变量与神经功能结果之间的可能相关性。
检查了 2012 年 1 月至 2019 年 7 月期间接受 ID-EMSCT 手术且采用 IONM 的患者的数据。术后 6 周和 1 年,根据神经状态计算 IONM 的灵敏度和特异性。将 IONM 测试结果与术前、术中及术后参数进行配对。
分析了 78 例患者的数据。术后 6 周,14.10%的患者神经功能状态恶化,术后 1 年下降至 9.84%。多模态 IONM 在术后 6 周时的灵敏度为 0.73(95%置信区间 [CI],0.39-0.94),特异性为 0.78(95% CI,0.66-0.87),术后 1 年时的灵敏度为 1.00(95% CI,0.54-1.00),特异性为 0.71(95% CI,0.57-0.82)。
IONM 的灵敏度高至完美,特异性高。然而,IONM 信号并不总是决定切除范围,而且假阳性结果并不总是导致肿瘤不完全切除,因为外科医生否决了 IONM。因此,IONM 不能完全替代临床判断和其他围手术期信息。